Mannatech, Inc. Stock Plummets to New 52-Week Low of $6.83

Mannatech, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 6.83 on February 27, 2026. This decline marks a significant downturn for the stock, which has experienced a 1-year performance drop of 14.69%, contrasting sharply with the S&P 500's gain of 17.36% during the same period. The company's financial metrics reveal a challenging landscape. Mannatech's market capitalization stands at USD 19 million, and it currently operates at a loss, with a negative return on equity of 23.83%. The stock's price-to-book ratio is 2.79, indicating a valuation that may not align with its financial performance. Additionally, the company has reported a net profit loss of USD 2.39 million, reflecting a significant decline of 150.84%. Institutional investor participation has also waned, with a 10.19% decrease in stakes over the last quarter, leaving them holding just 12.16% of the company. This trend, coupled with the stock's underperformance relative to broader market indices, underscores the challenges facing Mannatech, Inc. as it navigates a difficult financial environment.